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Purpose: Aim of the study was to investigate diagnostic accuracy of cardiac computed tomography angiography
(CCTA) between left ventricular end-systolic (LVES) and left ventricular end-diastolic (LVED) cardiac phase for
thrombus detection in patient’s prior to pulmonary vein isolation (PVI).
Materials and methods: 182 consecutive Patients with drug refractory AF scheduled for PVI (62.6% male, mean
age 64.1 ± 10.2 years) underwent routine pre-procedural evaluation including transesophageal echocardiography
(TEE) and CCTA for evaluation of left atrial (LA)/left atrial appendage (LAA) anatomy and thrombus formation.
Qualitative and quantitative analysis (using aorta ascendens (AA)/LAA ratio) was performed. Measurements of the
LA/LAA in LVES and LVED cardiac phase were obtained.
Results: End-systolic volumes (LA/LAA) measured in 30 patients without filling defects as control group and all 14
with filling defects of 182 patients were significantly larger (p < 0.01) than in end-diastolic phase. Qualitative analysis
was inferior to quantitative analysis using LA/LAA ratio (<0.5; accuracy: 100%, 88%,100%, 99% vs 100%). 5 out of 182
patients (2.7%) showed thrombus formation of the LAA in CCTA confirmed by TEE and quantitative analysis.
Intra/-interobserver variability was lower in end-systolic vs end-diastolic reconstruction interval.
Conclusion: For evaluating CCTA datasets in patients prior PVI, the LVES reconstruction interval is recommended
due to significantly larger LA/LAA volumes and lower intra/- interobserver variability’s.
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Atrial fibrillation (AF) is the most common sustained
cardiac arrhythmia with a significant increase of morbid-
ity and mortality due to its associated risk of thrombem-
bolism. Pulmonary vein isolation (PVI) by percutaneous
radiofrequency ablation has emerged as a therapeutic
option. Actually it is recommended for symptomatic and
drug refractory patients (Romero et al. 2013). In order to* Correspondence: wieland.staab@med.uni-goettingen.de
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in any medium, provided the original work is pprevent thrombembolic events, it is mandatory to exclude
left atrial (LA) and LA appendage (LAA) thrombus prior
to PVI (Dorenkamp et al. 2011; Scherr et al. 2009;
Hur et al. 2009). Transesophageal echocardiography
(TEE) is considered the gold standard modality in detecting
left atrial (LA)/LA appendage (LA/LAA) thrombi
(Dorenkamp et al. 2011; Scherr et al. 2009). However,
this is a semi-invasive procedure with rare but potential
life-threatening complications (Scherr et al. 2009). Cardiac
computed tomography angiography (CCTA) has been
proposed as an alternative method (Romero et al. 2013;
Dorenkamp et al. 2011; Scherr et al. 2009). Prior to PVI,
CCTA and TEE are used to provide exact anatomicalOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Patient demographic characteristics
Male 114 (62.6%)
Female 68 (37.4%)
Age, mean 64.1 ± 10.2
Age ≥ 75 years 15 (8.2%)
Mean ejection fraction 54.2 ± 6.1
Paroxysmal atrial fibrillation 119 (65.4%)
Persistent atrial fibrillation 63 (34.6%)
Cardiomyopathy (dilated) 9 (4.9%)
Mitral/aortic valve disease 29 (15.9%)
Serum creatinine; mg/dl 0.94 ± 0.27
Elevated serum creatinine 27 (14.8%)
CHADS 2 score:
CHADS2 = 0 41 (22.5%)
CHADS2 = 1 92 (50.5%)
CHADS2 = 2 36 (19.8%)
CHADS2 ≥ 3 13 (7.1%)
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and position of the pulmonary veins entering the left
atrium and to exclude LA/LAA thrombus (Gage et al.
2004). Reported limitations of CCTA are the high false
positive rate of thrombus formations and therefore
low specificity, unacceptable interobserver variability’s
(Aljaroudi et al. 2013).
Prospective electrocardiography (ECG) triggering became
available with newer scanner techniques, allowing data
acquisition during a pre-defined, narrow portion of
the R–R interval resulting in a reduction in radiation
dose (Steigner et al. 2009). Here, the mid-to-end-dia-
stole at 70 − 75% of the R-R interval is mostly used
for prospective-ECG- triggering, since coronary artery
motion is small in that phase (Menke et al. 2013). In
the traditional retrospective ECG-gated-CCTA method,
the full cardiac cycle is imaged (0-100%), and the heart is
retrospectively reconstructed at the required cardiac
phases (Dewey 2011). In this context, retrospective gating
is chosen because temporal as well as dynamic informa-
tion is obtained and CCTA images can be reconstructed
at other cardiac phases (0-100%), if the standard phase
was not diagnostic or interpretable (Steigner et al. 2009;
Menke et al. 2013). Therefore, we can choose appropriate
phases for minimum and maximum LA/LAA diameters
and volumes at end-diastole and end-systole for post-
processing and evaluating CCTA data. Aim of the study
was to investigate diagnostic performance of thrombus
detection in CCTA between cardiac cycles, intra/- inter-
observer variability’s of thrombus detection as well as
comparing acquired volumetric and diametric datasets.
Materials and methods
Patients
182 consecutive prospectively evaluated patients with AF
scheduled for PVI (62.6% male, mean age 64.1 ± 10.2 years,
Table 1) underwent routine diagnostic work up prior to
PVI including TEE and CCTA (from January 2010 until
May 2013). In all cases CCTA and TEE were performed
within 1–3 days prior to PVI. The analysis was approved
by the local ethic committee (University Medical Center
Göttingen). The CHADS2 scoring system (Romero et al.
2013; Scherr et al. 2009; Camm et al. 2012) was used for
risk stratification of thromboembolic events. The scoring
system assigns one point for the presence of age >75, heart
failure, diabetes mellitus and hypertension and two points
for prior transitory ischemic attack (TIA) or stroke. Further
risk factors of LA/LAA thrombus such as chronic kidney
disease, valvular disease, cardiomyopathy and LA size were
evaluated and documented (Camm et al. 2012), Table 2.
Computed tomography
CCTA was performed with a 64-slice MDCT scanner
(VCT LightSpeed, GE Healthcare, Milwaukee, WI, USA),slice collimation 64 × 0.625 mm; rotation time 600 msec;
tube voltage 100–120 kV; adaptive dose regime (auto
mAs, 280–380). Depending on the scan range and the
patient’s body weight the calculated mean radiation
dose was 6.1 ± 2.6 mSv (dose-length product range,
137 to 537 mGy * cm multiplied with the conversion
coefficient for the chest of k = 0.017 mSv mGy−1 cm −1).
Retrospective ECG gated half scan algorithm was used to
reconstruct the data into contiguous axial images with a
slice thickness of 0.625 mm. For this study, images were
evaluated at end- diastolic as well as end-systolic cardiac
cycle (39 ± 4% and 77 ± 5% of the RR-interval) on a dedi-
cated workstation (Aquarius 3D Workstation, TeraRecon,
San Mateo, CA, USA). Beta adrenergic blocking agents
were administered prior the scan procedure if the heart
rate was > 70 bpm (79% of the investigated patients)
(mean heart rate 61 ± 8 bpm). Contrast media injection
protocol (split-bolus) was as followed: injection of 30 ml
at 2 ml/sec of iodinated intravenous contrast agent
(Imeron 350, Bracco, Konstanz, Germany); a 20 sec break
followed by 70 ml at 4 ml/sec of the same contrast and a
40 ml saline chaser at 4 ml/sec in a single spiral scan
technique within a single breath-hold covering an
area from the aortic arch to below the diaphragm.
Semi-automatic bolus chasing was used to detect the
second contrast bolus in the ascending aorta. CCTA
images were analyzed separately at 39 ± 4 and 77 ± 5%
RR-interval (quantitative and qualitative analysis at
end-diastolic as well as end-systolic cardiac cycle
independently by both readers) blinded to TEE results by
two experienced independent readers. Complete CCTA
Datasets were evaluated by both readers independently at
two different time periods. Qualitative, visual assessment







N = 177 (97.3%) N = 5 (2.7%)
Male 110 (62.1%) 4 (80%) n.s.
Female 67 (37.9%) 1 (20%) n.s.
Age, mean 64.0 ± 8.8 68.8 ± 12.9 0.01
Mean ejection fraction 54.3 ± 6.0 48.6 ± 7.7 n.s.
Paroxysmal atrial fibrillation 116 (65.5%) 3 (60%) n.s.
Persistent atrial fibrillation 61 (34.5%) 2 (40%) n.s.
Cardiomyopathy (dilated) 9 (5.1%) 0 (0%) n.s.
Mitral/aortic valve disease 27 (15.3%) 2 (40%) n.s.
Serum creatinine; mg/dl 0.93 ± 0.27 1.12 ± 0.20 n.s.
Elevated serum creatinine 25 (14.1%) 2 (40%) n.s.
CHADS 2
Congestive heart failure 33 (18.6%) 1 (20%) n.s.
Hypertension 111 (62.7%) 4 (80%) n.s.
Diabetes mellitus 30 (16.9%) 4 (80%) 0.0004
Prior stroke or TIA 7 (4.0%) 0 (0%) n.s.
Age≥ 75 years 12 (6.8%) 3 (60%) <0.0001
CHADS2 = 0 41 (23.2%) 0 (0%) n.s.
CHADS2 = 1 92 (52.0%) 0 (0%) 0.009
CHADS2 = 2 33 (18.6%) 3 (60%) 0.02
CHADS2≥ 3 11 (6.2%) 2 (40%) 0.004
CHADS2: congestive heart failure, hypertension, age > 75 years, diabetes and
stroke (doubled).
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no-thrombus, contrast filling defect or definite thrombus
formation. A filling defect was defined as an intracavitary
low attenuating round or oval lesion representing
incomplete mixing of contrast agent and blood, whereas
thrombus formation was defined as round-or oval shaped
low attenuation (LAA/AA ratio < 0.5) area (Romero et al.
2013; Hur et al. 2009; Hur et al. 2013). Quantitative meas-
urement of relative contrast enhancement of the LA and
LAA to the ascending aorta was done in all patients. Here,
a 1 cm2 region of interest (ROI) was placed inside the
filling defect in the LAA seen on CCTA images and the
AA to generate the LAA/AA-ratio. In case no filling
defect was observed in CCTA images, a 1 cm2 ROI was as
well placed in the LAA and the AA for calculating LAA
attenuation to AAo attenuation values. A cut-off value of
LAA/AA ratio < 0.5 was used to differentiate between
thrombus and filling defect on CCTA.
Echocardiography
Transesophageal echocardiography (TEE) as well as trans-
thoracic echocardioagraphy (TTE) was performed in
all patients. TEE was obtained using a GE Vivid E9ultrasound system (General Electric Ultrasound, Horten,
Norway) with a 5.0 MHz multiplane probe acquiring
continuous cine loops of LA/LAA in 0° -180°. TTE was
used to determine left ventricular ejection fraction and LA
size. Images were acquired according to the methods
described by the American Society of Echocardiography
from parasternal long and short axis, long axis, apical four
chamber and two chamber views (Camm et al. 2012).
Highly experienced (at least 4 years experience) cardiolo-
gists performed and interpreted all TEEs blinded to
patient’s history and results from other procedures
such as CCTA. Thrombus was defined as a distinct
intracavitary echo-lucent or echo-dense mass in compari-
son to dense non-clearing spontaneous echo contrast
(SEC), defined as a slow swirling smoke like echo -density
(Scherr et al. 2009; Hur et al. 2009; Hur et al. 2013). The
teams of TEE/TTE and CCTA were blinded to the results
of the other modality during the assessment of LA/LAA
thrombus formation.
Definitions and measurements of LA/LAA
Reformats were done on a dedicated workstation
(Aquarius 3D Workstation, TeraRecon®, San Mateo, CA,
USA) (Figure 1). Minimal left atrial volume (LAV) was
defined at left ventricular (LV) end-diastole (ED) when
the LV was largest and LA smallest whereas maximum
LAV was defined at LV end-systole (ES) directly before
mitral valve opening when LAV was largest. The left
atrial appendage (LAA) was evaluated separately. LAV
was quantified according to a modified Simpson’s method
(Stojanovska et al. 2011). For quantifying LA diameters in
sagittal, coronal and axial direction, reformatted images
were obtained at the level of the aortic valve parallel to
the LV outflow tract in LVES for maximum LA diameters
and in LVED for minimum LA diameters. LAA was
measured according to this method for minimal
(LVED) and maximum (LVES) diameters and volumes.
As a statistical significant homogenous group, 14 patients
with detected thrombus or filling defect of LAA on CCTA
(Table 2) were assessed and 30 patients without filling
defects on CCTA 15 male (50%), 15 with persistent AF
(50%), mean age 62.3 ± 5.6 were evaluated as control group.
Intra/-intraobserver variability’s for data reproducibility was
independently obtained.
Statistical analysis
Biostatistics were planned and performed by the local
Department of Medical Statistics. Descriptive statistical
analyses, variables were expressed as the means ± standard
deviations and/or percentages. Intra/-interobserver agree-
ment for LA/LAA thrombus was calculated using Cohen’s
kappa (κ) statistics (kappa values: poor < 0.20, fair 0.21-0.40,
moderate 0.41 – 0.60, good 0.61-0.80, excellent 0.81-1.00).
Student’s t-tests and Fisher’s exact tests were used to
Figure 1 3 – Dimensional VR (A) with measured LA volume using the Simpsons method at LVED from a 71 year old female patient with
paroxysmal AF prior PVI; CCTA (B) demonstrates trabeculated fully opacified LAA with LAA/AA ratio from 0.99; CCTA (C) reconstructed in
oblique sagittal view showing LA at LVED on a dedicated workstation using TeraRecon ©; Corresponding TEE (D) shows trabecularisation
of the LAA without SEC or thrombus.
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categorical population differences or Chi-squares test for
eventually categorical variables for independence between
groups. Sensitivity, specificity, negative (NPV) and positive
predictive values (PPV) were assessed assuming TEE
as reference standard for thrombus detection by using
chi-squared test. For all obtained data, p < 0.05 was con-
sidered to be statistical significant. Statistical analysis was




Patient characteristics of all 182 consecutive patients
are summarized in Table 1. Image quality of all 182
consecutive CCTA examinations was regarded to be
diagnostic. Left atrial and left atrial appendage (LA/LAA)
evaluation was feasible in all cases and no adverse events
were reported during TEE and CCTA examination.
CCTA and TEE examinations were performed within
3 days (2 days ± 1). CCTA showed 14 out of 182 patients
with filling defects in the LAA. Using LAA/AAo ratio of
0.5, five patients showed definite thrombus formation,confirmed by TEE. These patients were excluded from
ablation procedure. Paroxysmal AF was present in 65.4%
of patients whereas 34.6% showed persistent AF. 78%
of patients were treated with phenprocumon at time of
CCTA and TEE exam, 17% used aspirin for anticoagulation.
At time of CCTA, AF was present in 61 patients (33.5%).
Thrombus formation in CCTA versus TEE and related
characteristics
In 5 cases a definitive thrombus formation using quantita-
tive analysis (cut-off value of LA/LAA coefficient < 0.5) was
seen in the LAA confirmed by TEE (Table 2). 9 patients
(3 with paroxysmal AF) showed filling defects without
definitive thrombus formation using quantitative analysis
(cut-off value of LA/LAA coefficient > 0.5, Figure 2)
judged as thrombotic precursors in the state of circulatory
stasis confirmed by TEE (all patients showed slow-flow/
SEC of the LAA). TEE identified 2 additional patients
with SEC in the LA or LAA that were missed by CCTA.
Patients with detected LAA thrombus (5 out of 182, 2.7%,
Figure 3) showed absolutely a lower mean ejection fraction
(54.3 ± 6.0% vs 48.6 ± 7.7%), a higher serum creatinine
(mg/dl) (0.93 ± 0.27 vs 1.12 ± 0.2) and relatively more
Figure 2 CCTA with filling defect (arrows) at LVED (A) and LVES (B); LAA is visually and quantitatively better opacified at LVES (A)
(LAA/AA ratio 0.51 (A) and 0.59 (B)) indicating SEC, excluding thrombus, confirmed by TEE (C) (arrows) in a 63 year old male patient
prior PVI with persistent AF.
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In concordance to the CHADS2 score, diabetes mellitus
(16.9% vs 80%, p value 0.0004) and age ≥ 75 (6.8% vs
60%, p value <0.0001) were significantly more preva-
lent in patients with LAA thrombus. Significantly
higher CHADS2 scores were present in patients with
thrombus (CHADS 2 = 2; 18.6% vs 60%, p value 0.02
and CHADS2 ≥ 3; 6.2% vs 40%, p value 0.004). LA/LAA
thrombus was not detected in patients with a CHADS2
score ≤ 1 and an age ≤ 50 years.
Measurements of LA and LAA
In 30 patients without thrombus, diameters as well as
volumes (absolute and indexed) were significantly larger
in the LVES at 39 ± 4% RR-interval (Table 3) (p < 0.01).
In 14 patients with filling defect on CCTA, diameters
and volumes as well as indexed values were significantly
larger in the LVES at 39 ± 4% RR-interval (p < 0.01) than
in LVED. Patients with thrombus showed larger diame-
ters and volumes as well as indexed values than patientsFigure 3 CCTA with depicted filling defect (arrows) in the LAA at LVE
0.17 (A) vs 0.18 (B)) in a 64 year old male patient with persistent AF c
higher density at LVES (B) and TEE.without (p < 0.01). Measurements were done blinded to
patient’s data 2 times within 6 weeks.
Intra-/Interobserver variability’s
Assuming TEE as standard of reference for detection of
thrombus or SEC, qualitative visual CCTA analysis at
77 ± 5% of RR-interval resulted in a sensitivity of 94%,
specificity of 84%, a negative predictive value (NPV) of
92% and a positive predictive value (PPV) of 87%
whereas visual evaluation at 39 ± 4% RR-interval showed
superior results of 100% sensitivity, 94% specificity, 100%
NPV and 93% PPV for both readers in consensus. Applying
a value of < 0.5 (LAA/AA ratio) relative contrast enhance-
ment in CCTA as a threshold of thrombus-formation, the
overall sensitivity, specificity, NPV and PPV were 100%
independently for both readers at both dates at 39 ± 4 and
77 ± 5% RR-Interval. Intra/-interobserver variability’s
were lower at absolute values at LVES in both readers
(39 ± 4% RR-interval; κ = 0.942 vs 0.901) vs LVED (77 ± 5%
RR-interval; κ = 0.891 vs 0.860).D (A) and LVES (B) showing thrombus formation (LAA/AA ratio
onfirmed by TEE (C). Additional visible SEC on top of thrombus with
Table 3 Measurements including diameters, volumes and indexed values of diameters and volumes showing
significant differences in volumes and diameters between LVED und LVES
Measurement 30 Patients without
filling defect at LVED
30 Patients without
filling defect at LVES
p-value 14 Patients with
filling defect at LVED
14 Patients with
filling defect at LVES
p-value
Diameter- axial (mm) 75.90+/− 7.95 87.10+/− 8.81 < 0.01 80.25+/− 7.74 88.85+/− 8.45 < 0.01
Diameter – sagittal (mm) 38.25+/− 6.6 53.10+/− 7.23 < 0 .01 46.70+/− 5.45 54.50+/− 6,77 < 0.01
Diameter – coronar (mm) 74.05+/− 9.3 79.90+/− 5,16 < 0.01 78.70+/− 9.32 85.50+/− 6.72 < 0.01
Volume- LA (mL) 169.50+/− 31.62 176.51+/− 34.57 < 0.01 187.00+/− 32.87 192.5+/− 33.59 0.026
Volume- LAA (mL) 6.673.45 9.39+/− 4.87 < 0.01 8.71+/− 2.24 10.72+/− 3.55 0.03
Diameter- axial/BSA (mm/m2) 37.64+/− 7.23 41.78+/− 6.56 < 0.01 38,83+/− 7.99 42.56+/− 6.43 < 0.01
Diameter – sagittal/BSA (mm/m2) 19.27+/− 4.08 26.33+/− 6.20 < 0.01 22.82+/− 5.79 26.18+/− 7.58 < 0.01
Diameter – coronar/BSA (mm/m2) 35.87+/− 6.06 40.16+/− 7.53 < 0.01 37.69+/− 8.01 40.941+/− 8.99 < 0.01
Volume- LA/BSA (mL/m2) 82.00+/− 21.68 85,80+/− 21.82 0.04 90.66+/− 23.58 93.65+/− 23.66 0.02
Volume- LAA/BSA (mL/m2) 3.2+/− 1.82 4.41+/− 2.23 0.035 4.14+/− 3.21 5.18+/− 2.87 0.25
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Main finding
Quantitative analysis (threshold of < 0.5 when using
LAA/AA ratio) of CCTA filling defects is superior to
qualitative visual analysis in detecting or ruling out
LA/LAA thrombus. For evaluating CCTA datasets in
patients prior to PVI, the LVES (at 39 ± 4% RR-interval)
reconstruction interval is recommended due to signifi-
cantly larger LA/LAA diameters/volumes (p < 0.01)
and lower intra/- interobserver variability’s (κ = 0.942 vs
κ = 0.891) in absolute values.
Thrombus formation
To minimize the risk of periprocedural thromboembolic
events during or after catheter ablation in the LA, it is
necessary to rule out LA/LAA thrombus formation prior
to PVI. TEE is an effective, reproducible method for
excluding intracavitary thrombi and actually remains the
gold-standard to assess LA/LAA thrombus formation
but sedation due to the invasiveness of the modality
(Camm et al. 2012). Various study protocols for detection
of LA/LAA thrombus have been described and discussed
in the past few years (Dorenkamp et al. 2011; Hur et al.
2009; Aljaroudi et al. 2013; Hur et al. 2013). Commonly
iodinated contrast agent is used in a single-bolus injection
with monophasic or biphasic (early/late phase imaging)
CT protocols (Dorenkamp et al. 2011; Hur et al. 2009;
Aljaroudi et al. 2013). A major limitation of CCTA is
incomplete contrast filling of the LAA, representing the
most frequent cause of false positive filling defects, leading
to a low PPV up to 30% (Hur et al. 2009; Aljaroudi et al.
2013). Wazni et al. (Wazni et al. 2007) reported no
increase of peri-procedural stroke if SEC was identified in
TEE. Additionally, even appropriate anticoagulation did
not have an influence on presence of SEC (Wazni et al.
2007). In the present study, 9 out of 11 patients with SEC
in TEE had non-thrombotic filling defects in CCTA in theLAA with a LAA/AA ratio >0.5. The frequency of 2.7%
intracardiac thrombus formations prior PVI is in line with
previous studies (Scherr et al. 2009). Here, pre-saturation
of the blood pool using a split-bolus injection single-scan
protocol seems to decrease non-thrombotic filling defects
by increasing contrast filling of the LAA and thus improv-
ing PPV. CCTA is not only able to evaluate LA/LAA
region, pulmonary veins but can as well identify coronary
artery placque and calcification with high sensitivity and
specificity for diagnosing coronary artery disease (CAD) in
patients with AF prior to PVI (Sohns et al. 2012).
Measurements of LA and LAA
Evaluation of LA volume and diameter is crucial prior
to PVI to adequately assess patients eligible for the
procedure as well as after ablation procedure to observe
or exclude post-procedural complications (Hur et al. 2009;
Stojanovska et al. 2011). Larger LA volumes and/or
diameters due to AF and LA/LAA thrombi are associated
with an increased risk of stroke and other embolic events
(Hur et al. 2009; Gage et al. 2004; Stojanovska et al. 2011).
The American Society of Echocardiography and the
European Association for Echocardiography proposed the
Simpsons method or the biplane area length method for
evaluation of LA volume and diameter (Calkins et al. 2012).
The Simpsons method is recommended while it does
not rely on geometric assumptions and LAA as well
as the ostia of the pulmonary veins are excluded from
analysis (Christiaens et al. 2009). Absolute as well as
indexed values of mean LA volume and diameter for
all ages were in line with previous published echocar-
diographic, computed tomography and cardiac MRI
data (Stojanovska et al. 2011; Christiaens et al. 2009;
Mahabadi et al. 2009; Hudsmith et al. 2007) when the
exact method of analysis was applied. Main differences to
the study were the method to evaluate the LA and LAA.
Here, Hudsmith et al. (Hudsmith et al. 2007), who used
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which therefore showed probably higher values. LA and
LAA volumes and diameters are in line with those previ-
ously published (Stojanovska et al. 2011; Hudsmith et al.
2007). Guidelines from the American Society of Echocar-
diography have recommended LAV measurement to be
used for LA size quantification in clinical practice (Calkins
et al. 2012). As shown in previous studies (Stojanovska
et al. 2011; Mahabadi et al. 2009; Hudsmith et al. 2007;
Martinez 2009) LA diameter and volume are significantly
influenced by BSA which indicates the need and appropri-
ateness of indexing LA volume and diameter to BSA for
reporting these parameters. Here, LAA volume and diam-
eters were evaluated separately. Therefore, we evaluated
absolute as well as indexed values in patients with parox-
ysmal and persistent AF as well as in patients with SEC
and thrombus, showing significantly larger volumes and
diameters in the LVES. However, the absolute as well as
indexed values reported in this study are in line with those
reported in previous published studies (Stojanovska et al.
2011; Christiaens et al. 2009; Mahabadi et al. 2009;
Hudsmith et al. 2007; Martinez 2009). Intra/-interobserver
variability’s were lower at LVES (39 ± 4% RR-interval;
κ = 0.942) vs LVED (77 ± 5% RR-interval; κ = 0.891) in
absolute values, it can be assumed due to larger LA/LAA
volumes and diameters (p < 0.01) at LVES cardiac cycle.
Prospective vs retrospective gating
In CCTA, prospective ECG-triggering needs overall less
radiation dose than retrospective ECG-gating but serves
less cardiac phases for evaluation (Menke et al. 2013).
Retrospective gating can be used with tube current
modulation, where the full tube dose is applied e.g. at
30 − 70% of the RR-interval and is (prospectively
ECG-based) reduced otherwise. Prospective gating is
usable with temporal padding where more than a
180° half-scan is needed, e.g. to image the 70 − 80%
RR-interval and to reconstruct the heart at 5% steps
afterwards. The target of the exposure can therefore be set
at 40% of the RR-interval (left atrium maximal volume)
on a prospective trigger approach (Menke et al. 2013;
Tsiflikas et al. 2010). Retrospective gating is preferable
in patients with tachyarrhythmia, because CCTA images
can be reconstructed at the required cardiac phase if the
standard phase (LVED; 75% of RR-interval) was non-
evaluatable (Menke et al. 2013). Prospective triggering is
most appropriate in patients with regular normal heart
rates and a maximum heart rate of about 75 beats/min.
Discussing the general rules of radiation protection, at
least in patients without tachyarrhythmia; CCTA could
be performed with a prospectively triggered low-dose
technique. Prospectively triggered CCTA should not be
inferior to the more radiation-intense retrospectively
gated method regarding the need for having reliablediagnostic information. Using a dual-source CT, all typical
referral patients are mostly eligible for prospectively
triggered CCTA due to the much faster image acquisition
(e.g., 83 ms) while using 2 x-ray sources (Menke et al.
2013; Tsiflikas et al. 2010). However, this may not be
suitable in patients with tachyarrhythmia, where even
retrospectively gated CCTA with dual-source CT may
be challenging (Sun et al. 2011).Limitations
In this study, we did not perform TEE or cardiac
MRI measurements on the same subjects to compare
the results with our LA/LAA diameters and volumes, but
the results correlate with previously published LA/LAA
diameters and values for MRI and TEE (Scherr et al. 2009;
Stojanovska et al. 2011; Christiaens et al. 2009; Mahabadi
et al. 2009; Hudsmith et al. 2007; Martinez 2009) obtained
with comparable method of analysis. Previous studies
(Stojanovska et al. 2011; Christiaens et al. 2009) have
indicated that enlargement of the LA body is often
not symmetric and that the antero-posterior LA linear
dimension measurement may not be the most accurate
and should not be used for risk stratification. Here, LA
volume measurement is more reproducible and accurate
for estimation of LA enlargement and may be predictive
of cardiovascular outcome (Stojanovska et al. 2011).
Physiologically, it can be assumed that LVES cardiac phase
shows larger diameters in comparison to the LVED
cardiac phase, therefore we performed measurements on
44 patients in this study as control group to proof this.
TEE was considered the reference standard for thrombus
and SEC detection. The absence or presence of LA
thrombus was not confirmed by direct visual inspection of
anatomic or surgical specimen. Despite that, TEE and
CCTA were not performed the same day. However
initial experience with a dual-source CT (DSCT) at our
institution using the described contrast injection-protocol
with a prospective trigger approach at LVES (39 ± 4%
RR-interval) looks promising while significantly reducing
radiation exposure to about <1-3 mSv.Conclusion
This is the first study to evaluate LA/LAA volumes
and sizes in context of thrombus detection in patients
prior to PVI at LVES and LVED cardiac cycle (39 ± 4%
and 77 ± 5% RR-interval). Here the LVES (at 39 ± 4%
RR-interval) reconstruction interval is recommended
due to significantly larger LA/LAA diameters/volumes
(p < 0.01) and lower intra/- interobserver variability’s
(κ = 0.942 vs κ = 0.891). Quantitative analysis (threshold
of < 0.5 when using LAA/AA ratio) of CCTA filling defects
is superior to qualitative visual analysis in detecting or
ruling out LA/LAA thrombus.
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